[go: up one dir, main page]

BRPI0818669A2 - formulação para melhora da função gastrintestinal - Google Patents

formulação para melhora da função gastrintestinal

Info

Publication number
BRPI0818669A2
BRPI0818669A2 BRPI0818669A BRPI0818669A BRPI0818669A2 BR PI0818669 A2 BRPI0818669 A2 BR PI0818669A2 BR PI0818669 A BRPI0818669 A BR PI0818669A BR PI0818669 A BRPI0818669 A BR PI0818669A BR PI0818669 A2 BRPI0818669 A2 BR PI0818669A2
Authority
BR
Brazil
Prior art keywords
formulation
gastrointestinal function
improving gastrointestinal
improving
function
Prior art date
Application number
BRPI0818669A
Other languages
English (en)
Inventor
Neu Josef
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of BRPI0818669A2 publication Critical patent/BRPI0818669A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0818669A 2007-10-14 2008-10-14 formulação para melhora da função gastrintestinal BRPI0818669A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97984507P 2007-10-14 2007-10-14
PCT/US2008/079849 WO2009052106A2 (en) 2007-10-14 2008-10-14 Formulation to improve gastrointestinal function

Publications (1)

Publication Number Publication Date
BRPI0818669A2 true BRPI0818669A2 (pt) 2017-05-02

Family

ID=40568048

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818669A BRPI0818669A2 (pt) 2007-10-14 2008-10-14 formulação para melhora da função gastrintestinal

Country Status (8)

Country Link
US (1) US9107894B2 (pt)
EP (1) EP2205235A4 (pt)
CN (1) CN101896176A (pt)
BR (1) BRPI0818669A2 (pt)
CA (1) CA2703042A1 (pt)
MX (1) MX2010004110A (pt)
RU (1) RU2010119238A (pt)
WO (1) WO2009052106A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110086809A1 (en) * 2009-10-14 2011-04-14 Joshua Anthony Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
RU2694195C2 (ru) * 2014-09-30 2019-07-09 Нестек С.А. Питательная композиция для применения при активации формирования и/или регенерации кишечника и/или печени
EP3612570A4 (en) 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
IT201700050442A1 (it) * 2017-05-10 2018-11-10 Fusion Farm S R L Composizione per la prevenzione del danno intestinale
CN107736614A (zh) * 2017-08-29 2018-02-27 上海市儿科医学研究所 含丁酸的营养制剂
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229136A (en) * 1992-05-21 1993-07-20 Clintec Nutrition Co. Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
ES2195555T3 (es) 1998-03-31 2003-12-01 Nestle Sa Empleo de composiciones para proporcionar glutamina.
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US20060229256A1 (en) * 2003-09-26 2006-10-12 Bristol-Myers Squibb Company Enternal administration of arginine and glutamine for abnormal vascular proliferation

Also Published As

Publication number Publication date
US20100222271A1 (en) 2010-09-02
RU2010119238A (ru) 2011-11-27
EP2205235A2 (en) 2010-07-14
MX2010004110A (es) 2010-07-28
WO2009052106A2 (en) 2009-04-23
CA2703042A1 (en) 2009-04-23
WO2009052106A3 (en) 2009-06-04
EP2205235A4 (en) 2010-11-17
CN101896176A (zh) 2010-11-24
US9107894B2 (en) 2015-08-18

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0721651A2 (pt) Composição farmacêutica
DK2234600T3 (da) Antistofformulering
RU2493831C3 (ru) Фармацевтические композиции
BRPI0813775A2 (pt) Composição
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0818079A2 (pt) composição de lipideo
BRPI0814188A2 (pt) Formulações
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0818669A2 (pt) formulação para melhora da função gastrintestinal
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
DK2125048T3 (da) Præparat
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0921654A2 (pt) formulação farmacêutica
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0921313A2 (pt) composição farmaucêutica
EP2197828A4 (en) FULLERENE MULTI-ADDUCT COMPOSITIONS
HRP20171852T1 (hr) Dijetetski purgativi
BRPI0820198A2 (pt) composições farmacêuticas
BRPI0811002A2 (pt) Composição biofertilizante
EP2207567A4 (en) IMMUNOGENIC FORMULATIONS
BRPI0820960A2 (pt) composição
BRPI0912171A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]